"If approved, we are ready to offer a convenient, once-daily pill that can be scaled globally -- removing barriers and redefining how obesity is treated around the world," Kenneth Custer, Eli Lilly's executive vice president and president of Lilly Cardiometabolic Health, said in a statement
An oral treatment could provide several potential advantages: Greater Convenience: Many patients prefer taking a daily pill rather than administering injections
If nothing has changed by six months of consistent use alongside lifestyle support, it's reasonable to revisit the plan with your GP or specialist
Delaloye, Lausanne (Gyncologie-obsttrique)
As for why GLP-1s might cause hair loss, the most likely explanation is the rapid or substantial weight loss that people can experience while on them, according to the authors
After eating a meal, GLP-1 works by binding to receptors which send messages to the body to increase the amount of insulin released